Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - CASH & EQUIVALENTS
Cash & Equivalents RGNX - REGENXBIO Inc.
34.5 M
LAST VALUE
-68.38%
2 YEAR CAGR
-14.50%
5 YEAR CAGR
40.91%
10 YEAR CAGR